Marriage Counselors in El Dorado, CA Accepting Medicare
2 Marriage Counselors found. Showing 1 - 2
 Courtney Jean Uppendahl, LMFT Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: Po Box 1312, El Dorado, CA 95623 Phone: 530-497-0909 |
 Mr. John H. Prock, MFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 6980 Crystal Blvd, El Dorado, CA 95623 Phone: 530-620-5577 |
News Archive
Detergent manufacturers in search for phosphate-free formulas
Phosphate-free automatic dishwashing detergents - introduced to combat the phosphate-fed algae blooms that foul the nation's lakes and rivers - may be making the fish happy. But they're putting a frown on the faces of some consumers who say the new products leave dishes dirty. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
Columbia University researchers find link between firearm-related laws and firearm homicides
A study by researchers at Columbia University's Mailman School of Public Health looked at the associations between firearm-related laws and firearm homicides, suicides, and unintentional injuries and deaths. The paper is the first to explore the evidence from around the world on gun laws and gun violence to determine whether gun restrictions help reduce gun deaths. While the research did not conclusively prove that restrictions, or relaxation of laws, reduce gun deaths, the results indicate that gun violence tended to decline after countries passed new restrictions on gun purchasing and ownership
Study shows that PCCs can reverse blood thinning effects of XARELTO in healthy subjects
Janssen Research & Development, LLC announced today results of an open label, single-center, parallel group study showing that a type of medication called prothrombin complex concentrates can reverse the blood thinning effects of XARELTO (rivaroxaban) in healthy subjects.
Grunenthal Group submits Marketing Authorization Application to EMA for ZALVISO
AcelRx Pharmaceuticals, Inc. and Grunenthal Group announced today that Grunenthal has submitted a Marketing Authorization Application (MAA) to the European Medicines Authority for ZALVISO for the management of moderate to severe acute pain in adult patients in a medically supervised environment.
HER2 proteins do not predict breast cancer patient's outcome after Herceptin treatment
Precisely quantifying the amount of three different HER growth proteins, along with several other proteins believed linked to breast cancer, did not predict a patient's outcome after treatment for HER2-Positive Breast Cancer with Herceptin, say Mayo Clinic researchers.
› Verified 8 days ago